Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion type Assertion NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_head.
- NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion description "[A human hepatoblastoma cell line (C3A, a subclone of HepG2/C3 that is currently being used as a surrogate liver) and human lung adenocarcinoma cells (A549) were stimulated with interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF alpha), interferon-gamma (IFN gamma), or IL-6 to determine any differences in cell type responsiveness to individual cytokines for ICAM-1 upregulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_provenance.
- NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion evidence source_evidence_literature NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_provenance.
- NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion SIO_000772 7657294 NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_provenance.
- NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion wasDerivedFrom befree-2016 NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_provenance.
- NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_assertion wasGeneratedBy ECO_0000203 NP1316758.RA3zM1vbzkJZJJr-4-l4k6iP6TfePT6VKmAtcJRp9xVJA130_provenance.